©2022 Stanford Medicine
68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer
Not Recruiting
Trial ID: NCT02488070
Purpose
This clinical trial studies gallium-68 (68Ga)-prostate specific membrane antigen (PSMA)
(gallium Ga 68-labeled PSMA ligand Glu-urea-Lys[Ahx]) positron emission tomography
(PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) in identifying
prostate cancer that may have returned after a period of improvement (biochemical
recurrence). 68Ga-PSMA is a radiopharmaceutical that localizes to a specific prostate cancer
receptor, which can then be imaged by the PET/CT or PET/MRI scanner.
Official Title
68Ga-PSMA PET/CT or PET/MRI in the Evaluation of Patients With Prostate Cancer: A Feasibility Study
Stanford Investigator(s)
Sandy Srinivas
Professor of Medicine (Oncology) and, by courtesy, of Urology
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Geoffrey Sonn
Associate Professor of Urology and, by courtesy, of Radiology (Body MRI)
Andreas Loening
Assistant Professor of Radiology (Body MRI)
Eligibility
Inclusion Criteria:
- Provides written informed consent
- Known diagnosis of prostate cancer
- Patient has suspected recurrence based on biochemical data (prostate specific antigen
[PSA] > 2 ng/mL)
- Able to remain still for duration of each imaging procedure (about one hour)
Exclusion Criteria:
- Unable to provide informed consent
- Inability to lie still for the entire imaging time
- Inability to complete the needed investigational and standard-of-care imaging
examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
- Any additional medical condition, serious intercurrent illness, or other extenuating
circumstance that, in the opinion of the Investigator, may significantly interfere
with study compliance
Intervention(s):
drug: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)
procedure: Computed Tomography
procedure: Magnetic Resonance Imaging
procedure: Positron Emission Tomography
procedure: Positron Emission Tomography
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061